---
type: industry_information
cover: []
date: 2021-03-15T05:00:00.000+08:00
title: Take2 Prophecy™ is Now Serving More than 20,000 Employees Upon Launching on
  HSBC Life Benefits+
detail: 'Since March 2021, the Take2 Prophecy™ Test for Nasopharyngeal Cancer and
  related health assessment services are available on HSBC Life Benefits+ as one of
  the new employee benefits. '
href: ''
slug: launch-on-hsbc-life-benefit
languages:
- en
hide: false

---
Since March 2021, the Take2 Prophecy™ Test for Nasopharyngeal Cancer (“the Test”) and related health assessment services are available on HSBC Life Benefits+ as one of the new employee benefits. At present, all employees of HSBC, Hang Seng Bank and other subsidiaries of the HSBC Group can access the Test with a special offer on their one-stop group medical benefits platform.

Take2 Health is excited to team up with respectable corporations to raise the awareness of early cancer detection in the local communities. The Test has received noticeable attention from users during the initial phase of the launch, showing the public’s demand for early cancer detection services. Take2 Health will continue devoting its dedication to providing early cancer detection services with varieties, aiming to bring benefit to the public.